PURPOSE: The HOX genes are a family of homeodomain containing transcription factors that determine embryonic tissue identity and also have regulatory and oncogenic roles in adult cells. We quantified the expression of HOX genes in normal kidney tissue, primary tumors and derived cell lines, and examined their role in renal cancer cell survival. MATERIALS AND METHODS: Quantitative polymerase chain reaction was used to evaluate HOX gene expression in cells and tissues. HOX gene function was disrupted using a peptide that blocks the interaction between HOX proteins and their PBX cofactor. Apoptosis was assessed by annexin/propidium iodide staining and direct measurement of caspase activity. RESULTS: Primary renal tumors and derived cell lines showed abnormal HOX gene expression. Furthermore, blocking HOX activity by targeting the interaction between HOX and its cofactor PBX caused apoptotic and necrotic cell death in the renal cancer cell lines CaKi-2 and 769-P, while sparing normal adult kidney cells. CONCLUSIONS: Our findings suggest that the HOX/PBX dimer is a potential therapeutic target in renal cancer.
PURPOSE: The HOX genes are a family of homeodomain containing transcription factors that determine embryonic tissue identity and also have regulatory and oncogenic roles in adult cells. We quantified the expression of HOX genes in normal kidney tissue, primary tumors and derived cell lines, and examined their role in renal cancer cell survival. MATERIALS AND METHODS: Quantitative polymerase chain reaction was used to evaluate HOX gene expression in cells and tissues. HOX gene function was disrupted using a peptide that blocks the interaction between HOX proteins and their PBX cofactor. Apoptosis was assessed by annexin/propidium iodide staining and direct measurement of caspase activity. RESULTS:Primary renal tumors and derived cell lines showed abnormal HOX gene expression. Furthermore, blocking HOX activity by targeting the interaction between HOX and its cofactor PBX caused apoptotic and necrotic cell death in the renal cancer cell lines CaKi-2 and 769-P, while sparing normal adult kidney cells. CONCLUSIONS: Our findings suggest that the HOX/PBX dimer is a potential therapeutic target in renal cancer.
Authors: S V Bontha; D G Maluf; K J Archer; C I Dumur; M G Dozmorov; A L King; E Akalin; T F Mueller; L Gallon; V R Mas Journal: Am J Transplant Date: 2017-07-08 Impact factor: 8.086
Authors: Zoë L Kelly; Agnieszka Michael; Simon Butler-Manuel; Hardev S Pandha; Richard Gl Morgan Journal: J Ovarian Res Date: 2011-09-09 Impact factor: 4.234
Authors: H Kocak; S Ackermann; B Hero; Y Kahlert; A Oberthuer; D Juraeva; F Roels; J Theissen; F Westermann; H Deubzer; V Ehemann; B Brors; M Odenthal; F Berthold; M Fischer Journal: Cell Death Dis Date: 2013-04-11 Impact factor: 8.469